|
2025 Conference Publication Development of quantitative CT image analysis for NTM lung disease interventionsMakani, Punitkumar, Mollica, Federico, Bonte, Merlijn, Burke, Andrew, Hicks, Daniel, Thomson, Rachel, Wainwright, Claire, Tiddens, Harm and Caudri, Daan (2025). Development of quantitative CT image analysis for NTM lung disease interventions. European-Respiratory-Society Congress (ERS), Amsterdam Netherlands, Sep 27-Oct 01, 2025. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2025.PA3971 |
|
2025 Conference Publication Adverse events related to study drugs in finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT) trialWainwright, C., Hicks, D., Rice, M., Jong, T., Gailer, N., Joshi, S., Wang, X., Burke, A., Thomson, R., Grimwood, K., Bell, S. and Clark, J. (2025). Adverse events related to study drugs in finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT) trial. 48th European Cystic Fibrosis Conference, Milan, Italy, 4-7 June 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.jcf.2025.03.118 |
|
2025 Conference Publication Prevalence of nausea and vomiting and anti-emetic use in the tinding the optimal regimen for Mycobacterium abscessus treatment (Format) trialWainwright, C., Hicks, D., Rice, M., Jong, T., Joshi, S., Wang, X., Burke, A., Thomson, R., Grimwood, K., Bell, S. and Clark, J. (2025). Prevalence of nausea and vomiting and anti-emetic use in the tinding the optimal regimen for Mycobacterium abscessus treatment (Format) trial. 48th European Cystic Fibrosis Conference, Milan, Italy, 4-7 June 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.jcf.2025.03.119 |
|
2025 Conference Publication Prevalence of Nausea and Vomiting and Anti-emetic Use in the Finding the Optimal Regimen for Mycobacteroides Abscessus Treatment (FORMaT) TrialThomson, R., Hicks, D., Rice, M., Jong, T., Joshi, S., Wang, X., Burke, A.J., Grimwood, K., Bell, S., Clark, J. and Wainwright, C.E. (2025). Prevalence of Nausea and Vomiting and Anti-emetic Use in the Finding the Optimal Regimen for Mycobacteroides Abscessus Treatment (FORMaT) Trial. ATS International Conference, San Francisco, CA United States, 16-21 May 2025. New York, NY United States: American Thoracic Society. doi: 10.1164/ajrccm.2025.211.abstracts.a7277 |
|
2025 Conference Publication Adverse Events Related to Study Drugs in Finding the Optimal Regimen for Mycobacteroides Abscessus Treatment (Format) TrialThomson, R., Hicks, D., Rice, M., Jong, T., Gailer, N., Joshi, S., Wang, X., Burke, A.J., Grimwood, K., Bell, S., Clark, J. and Wainwright, C.E. (2025). Adverse Events Related to Study Drugs in Finding the Optimal Regimen for Mycobacteroides Abscessus Treatment (Format) Trial. ATS International Conference, San Francisco, CA, United States, 16-21 May 2025. New York, NY United States: American Thoracic Society. doi: 10.1164/ajrccm.2025.211.abstracts.a7278 |
|
2025 Conference Publication Real-world Experience With Inhaled Liposomal Amikacin Suspension for Treatment of Nontuberculous Mycobacterial Pulmonary DiseaseTwining, M., Kang, S., Riddles, T., Evans, I., Burke, A.J. and Thomson, R. (2025). Real-world Experience With Inhaled Liposomal Amikacin Suspension for Treatment of Nontuberculous Mycobacterial Pulmonary Disease. ATS International Conference, San Francisco, CA United States, 16-21 May 2025. New York, NY United States: American Thoracic Society. doi: 10.1164/ajrccm.2025.211.abstracts.a5444 |
|
2025 Conference Publication Adverse events related to study drugs in finding the optimal regimen for mycobacterium abscessus treatment (format) trialHicks, D., Rice, M., Jong, T., Gailer, N., Joshi, S., Wang, X., Thomson, R., Burke, A., Grimwood, K., Bell, S., Clark, J. and Wainwright, C. (2025). Adverse events related to study drugs in finding the optimal regimen for mycobacterium abscessus treatment (format) trial. TSANZSRS Annual Scientific meeting 2025, Adelaide, SA Australia, 21-25 March 2025. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Conference Publication Rifabutin induces Elexacaftor metabolism in Mycobacterium abscessus-related pulmonary disease: A case studyMattison, Graeme, Keating, Rebecca, McWhinney, Brett, Connors, Shannon, Swenson, Rebecca, Evans, Ieuan, Burke, Andrew and Burr, Lucy (2024). Rifabutin induces Elexacaftor metabolism in Mycobacterium abscessus-related pulmonary disease: A case study. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD Australia, 2–4 August 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Conference Publication Developing a pharmacovigilance framework for an investigator led, non-commercial international adaptive platform trialRice, Megan, Hicks, Daniel, Jong, Tiffany, Gailer, Nicolas, Joshi, Sri, Stevens, Luke, Lee, Kate, Thomson, Rachel, Burke, Andrew, Grimwood, Keith, Bell, Scott, Clark, Julia and Wainwright, Claire E. (2024). Developing a pharmacovigilance framework for an investigator led, non-commercial international adaptive platform trial. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2–4 August 2024. Richmond, VIC, Australia: John Wiley & Sons. |
|
2024 Conference Publication Developing a pharmacovigilance framework for an investigator-led, non-commercial platform trial – finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT)Hicks, D., Jong, T., Rice, M., Gailer, N., Joshi, S., Stevens, L., Lee, K., Thomson, R., Burke, A., Grimwood, K., Bell, S., Clark, J. and Wainwright, C.E. (2024). Developing a pharmacovigilance framework for an investigator-led, non-commercial platform trial – finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT). 47th European Cystic Fibrosis Conference, Glasgow, United Kingdom, 5-8 June 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s1569-1993(24)00244-3 |
|
2024 Conference Publication Performance of next generation molecular methods in diagnosing pleural space infectionBaird, T., Bell, P., Goddard, J., Olagoke, O., Burke, A., Subedi, S., Davey, T., Anderson, J., Sarovich, D. and Price, E. (2024). Performance of next generation molecular methods in diagnosing pleural space infection. HOBOKEN: WILEY. |
|
2023 Conference Publication Mycobacterium abscessus: Acquisition and transmission pathwaysRamsay, K., Smith, K., Carter, R., Clayton, M., Burke, A., Wainwright, C., Thomson, R. and Bell, S. (2023). Mycobacterium abscessus: Acquisition and transmission pathways. TSANZSRS 2023 The Australia and New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health and Respiratory Science, Christchurch, New Zealand, 25–28 March 2023. Richmond, VIC Australia: John Wiley and Sons. doi: 10.1111/resp.14459 |
|
2022 Conference Publication Anticoagulation and antiplatelet strategies in non-critically ill patients with Covid-19McQuilten, Zoe, Venkatesh, Balasubramanian, Jha, Vivekanand, Roberts, Jason, Morpeth, Susan, Totterdell, James, McPhee, Grace, Abraham, John, Bam, Niraj, Bandara, Methma, Bangi, Ashpak, Barina, Lauren, Basnet, Bhupendra, Bhally, Hasan, Bhusal, Khemr, Bogati, Umesh, Bowen, Asha, Burke, Andrew, Christopher, Devasahayam, Chunilal, Sanjeev, Cochrane, Belinda, Curnow, Jennifer, Reddy, Varaprasad Babu Dara, Das, Santa, Dhungana, Ashesh, Di Tanna, Gian Luca, Dotel, Ravindra, DSouza, Hyjel, Dummer, Jack ... Tong, Steven Y. C. (2022). Anticoagulation and antiplatelet strategies in non-critically ill patients with Covid-19. 64th Annual Meeting and Exposition of the American Society of Hematology (ASH), New Orleans, LA United States, 10-13 December 2022. Amsterdam, Netherlands: Elsevier. doi: 10.1182/blood-2022-168448 |
|
2022 Conference Publication Home-based treatment of nontuberculous mycobacteria pulmonary disease via a novel nitric oxide generator and delivery systemThomson, Rachel M., Morgan, Lucy C., Burke, Andrew, Colin, Andrew A. and Tal, Asher (2022). HOME-BASED TREATMENT OF NONTUBERCULOUS MYCOBACTERIA PULMONARY DISEASE VIA A NOVEL NITRIC OXIDE GENERATOR AND DELIVERY SYSTEM. Annual Meeting of the American-College-of-Chest-Physicians (CHEST), Nashville Tn, Oct 16-19, 2022. AMSTERDAM: ELSEVIER. doi: 10.1016/j.chest.2022.08.361 |
|
2018 Conference Publication Low utility of microbiology testing in community acquired pneumoniaKudo, M., Johnson, J. and Burke, A. (2018). Low utility of microbiology testing in community acquired pneumonia. The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting, Adelaide, SA, Australia, 23–27 March 2018. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.13268 |
|
2017 Conference Publication High Rates of Respiratory Symptoms and Airways Disease in Mental Health Inpatients in a Tertiary CentreBurke, Andrew, Hay, Karen, Chadwick, Alex and Sheridan, Judith (2017). High Rates of Respiratory Symptoms and Airways Disease in Mental Health Inpatients in a Tertiary Centre. The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting, Canberra, ACT, Australia, 24–28 March 2017. Richmond, Australia: Wiley-Blackwell Publishing. |
|
2013 Conference Publication Personalized care for COPD: the "COPD Snapshot"Hakim, R., Mccarthy, L., Masel, P. J., Bowman, R. V., Burke, A., Bazdar, S., Serginson, J. G. and Yang, I. A. (2013). Personalized care for COPD: the "COPD Snapshot". Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2013 Annual Scientific Meetings, Darwin, NT, Australia, 22-27 March 2013. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/resp.12045 |
|
2012 Conference Publication Bronchoscopy and Transthoracic-Needle Aspiration Yield for Histomorpho-Molecular DiagnosisDaniels, M. G., Leong, S., Bowman, R. V., Yang, I. A., Masel, P., Fiene, A., Robinson, P., Burke, A., McKeon, J., Ayres, J., Duhig, E., Clarke, B., Tran, K., Godbolt, D., Dettrick, A. and Fong, K. M. (2012). Bronchoscopy and Transthoracic-Needle Aspiration Yield for Histomorpho-Molecular Diagnosis. 4th Australian Lung Cancer Conference, Adelaide Australia, 23-25 August 2012. New York, NY, United States: Elsevier. |
|
2011 Conference Publication Community Acquired Respiratory Viral Infection Is a Risk Factor for Death after Lung TransplantationChambers, D. C., Burke, A., Daniels, T. W. V., Yerkovich, S. T. and Hopkins, P. M. A. (2011). Community Acquired Respiratory Viral Infection Is a Risk Factor for Death after Lung Transplantation. 31st Annual Meeting and Scientific Sessions on International-Society-for-Heart-and-Lung-Transplantation, San Diego CA, United States, 13-16 April 2011. New York, NY, United States: Elsevier. doi: 10.1016/j.healun.2011.01.360 |
